🇺🇸 FDA
Pipeline program

OCTREOTIDE ACETATE, Paltusotine tablets

CRN00808-11

Phase 2 small_molecule active

Quick answer

OCTREOTIDE ACETATE, Paltusotine tablets for Carcinoid Syndrome is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Carcinoid Syndrome
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials